Japan HIV Tragedy Produces Proposed New Laws

29 May 1997

The Japanese Ministry of Health and Welfare has set up a committee todraw up plans to increase the availability of medical information, which could include requiring doctors to show patients their medical charts. The group is to hold its first meeting this month.

The MHW says the current shortage of information supplied to patients was to blame for the infection with HIV of hemophiliacs from contaminated blood products in the 1980s. However, a MHW official quoted in The Japan Times queried whether, as doctors in Japan do not always inform cancer and terminally-ill patients of their diseases, all the content of the chart should be shown to a patient.

The MHW is also proposing legislation allowing Japan to become self-sufficient in the supply of blood products. The bill, expected to be presented at the next ordinary Diet (parliament) session in January, will make the government responsible for supervising the activities of blood product manufacturers and the Japanese Red Cross Society.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight